Evidence map›Paper›PMID 34519165›Full record

ArticleThoracic cancer2021

Evidence for marked underutilization of insurance billing in malignant pleural mesothelioma in Finland.

Paulus Torkki, Juuso Paajanen, Ville Kytö, Sanna Laaksonen, Jari Räsänen, Marjukka Myllärniemi, Ilkka Ilonen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Thoracic cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Paulus TorkkiDepartment of Public Health, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Juuso PaajanenHeart and Lung Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.ORCID 0000-0002-4364-2201
Ville KytöDepartment of Public Health, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Sanna LaaksonenIndividualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Jari RäsänenHeart and Lung Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Marjukka MyllärniemiHeart and Lung Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Ilkka IlonenHeart and Lung Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSubstantial variation in health care costs for malignant pleural mesothelioma (MPM) has previously been identified. MATERIALS AND

methodsWe analyzed the changes in health care costs in MPM in Finland during 2002-2012. Finland has low-threshold public health care and a mandatory Workers' Compensation scheme that covers all occupational-related disease expenses. The costs include treatment costs for inpatients, hospice care, medication costs, rehabilitation costs, and travel costs. All costs are expressed in 2012 prices, adjusted using the consumer price index.

resultsA total of 907 MPM patients were included in the study. Mean duration of inpatient episodes increased 7% per year from 2002 to 2012, correlating with total costs (R

conclusionDuring the study period, we found that the costs of MPM increased more than the average health care costs. This may be because of advanced diagnostic workup or more costly treatment (e.g., pemetrexed). Moreover, only one-third of all health care costs are charged to Workers' Compensation Insurance.

Indexed as

FinlandHealth Care CostsHumansInsurance, HealthMesothelioma, MalignantRetrospective Studiesasbestoshealth care costsmalignant pleural mesotheliomaoccupational disease

Identifiers

PMID34519165
PMCPMC8487819

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.